1-hexadecyl-3-methylimidazolium chloride

structure in first source

Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

1.	Hepatocellular Carcinoma (Hepatoma) 10/01/2018 - "Our study aims to evaluate the toxicity of 1-hexadecyl-3-methylimidazolium chloride ([C16min]Cl) to human hepatocellular carcinoma (HepG2) cells, including cell viability, genotoxicity, oxidative stress, apoptosis, cell cycle, and apoptosis-related gene expression. "
2.	Carcinoma (Carcinomatosis) 10/30/2018 - "Our study aimed to evaluate the toxicity of 1-hexadecyl-3-methylimidazolium chloride ([C16min]Cl) on the human cervical carcinoma (Hela) cells. "